⚡️ High Specific Activity Radiochemistry & SSTR2 Targeting

Bexlutry pairs high specific activity, no-carrier-added Lutetium-177 with edotreotide, an engineered synthetic peptide vector with high affinity for somatostatin SSTR2 receptors overexpressed on neuroendocrine tumors.

Upon receptor internalization, 177Lu emits localized beta particles with a mean tissue penetration of only 1.8 mm, inflicting lethal DNA double-strand breaks in malignant cells while sparing healthy adjacent organs. Renal clearance was accelerated by 45%.

📊 Radiochemical & Physical Telemetry of Bexlutry

: 177-Lutetium n.c.a. (> 99% purity)

: 1.8 mm in tissue

: -45% retention

: 6.64 days (ideal for global transport)

⏳ 72-Hour Isotope Lifecycle: Nuclear Logistics Timeline